Bluewater Bio International Has Entered Into a Licencing Agreement

Bluewater Bio International has entered into a licencing agreement with NeoTech Aqua Solutions Inc to market the US company's ultra-efficient, highly advanced UV technologies to industrial and municipal clients. The licence is global, with exclusive territory rights that include the UK and Ireland. NeoTech's UV technology uses a patented chamber design combined with ReFleX technology which reflects over 99% of the UV generated back into the treated water, continuously until the target contaminant is destroyed. NeoTech, based in San Diego, California, already has more than 300 installations for its patented ultra-efficient UV technology, selling into the food & beverage, bottled water, pharmaceutical, pools & water parks, microelectronics, wastewater, remediation, and municipal drinking water markets – both for disinfection and for the elimination of organic contaminants (TOC). Bluewater Bio believes there is an excellent growth market for efficient UV technology in territories that they or their partners currently operate in, and that its FilterClear multimedia filtration technology and Neotech UV are ideal complementary technologies for ultra-efficient filtration and subsequent disinfection. Daniel Ishag, founder and CEO of Bluewater Bio International, said: "As we look to increase our product platform and service the needs of our ever increasing customer base, this deal signifies an important step in realising that aim. We aspire to be the world's leading independent water technology provider. I strongly believe that, with Neotech onboard, we are ever closer to achieving this." NeoTech's president and CEO Stephen Dunham said: "The NeoTech team welcomes the opportunity to move forward globally in cooperation with Bluewater Bio. The synergistic advantages of leveraging BlueWater Bio's existing technology, global footprint and corporate assets with NeoTech's unique technological strengths in UV renders a new, multi-faceted capability that will benefit both companies and particularly the market at large. This is an exciting time of expansion for our respective technologies."